Table 2.

Liver Transplant Recipients with Biopsy-Proven Chronic CNI Toxicity

Baseline Characteristics
	TAC	CsA
Number of Patients	9	6
Year of Transplant	1995–2005	1995–2005
Age at transplant (years)	55.8±2.6	53.5±3.6
White Race	8	5
Male Gender	5	3
Time to Biopsy (years)	4.3±0.6	6.4±0.8
coexisting Diabetes	4	4
coexisting HTN	9	5
Serum creatinine at biopsy (mg/dL)	1.5±0.9	1.6±0.08
Proteinuria on urinalysis > 1 +	3	2
Follow-up after biopsy (years)	2.9±0.2	2.1±0.3
Last serum creatinine (mg/dL)	1.9±0.7	1.8±0.7

CNI: Calcineurin inhibitor, CsA: Cyclosporine A, TAC: Tacrolimus, HTN: Hypertension